A Clinical Trial for People with Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)

Study Title: A Study to Evaluate Efficacy and Safety of BMS-986165 in Adults With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) - IM011-132 Sponsor Name: Bristol-Myers Squibb (BMS) Purpose of Study: The purpose of this study is to see if a study medication…


World Lupus Federation Global Survey of People Living with Lupus Finds 87% Report at Least One Major Organ Affected by the Disease

In a recent international survey, the World Lupus Federation found that 87% of the survey respondents living with lupus reported that the disease has impacted one or more major organs or organ systems. Over 6,700 people with lupus participated in the survey from over 100 countries.

Global Advisory Committee Identifies Solutions for Addressing Top Lupus Barriers

The Addressing Lupus Pillars for Health Advancement (ALPHA) project is a unique global consensus initiative that seeks to identify and prioritize the fundamental barriers or knowledge gaps that will allow providers, researchers and scientists to improve diagnosis, treatment and systems of care for people with lupus.